RecruitingNCT06472804
Insomnia in Patients With Metastatic Lung Cancer
Insomnia in Patients With Metastatic Non Small Cell Lung Cancer
Sponsor
Mayo Clinic
Enrollment
60 participants
Start Date
Jun 19, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Have a diagnosis of metastatic non small cell lung cancer
- Undergoing 1st, 2nd or 3rd line of treatment or are in maintenance therapy
- Older than 18 years old at the time of diagnosis
Exclusion Criteria1
- Subjects will be excluded if they are considered to have advanced terminal cancer, severe depression or other psychiatric disorder or a sleep disorder other than insomnia (sleep apnea, restless leg syndrome, sleep related disorder of breathing), regular use of psychotropic medication other than hypnotics (eg antidepressants) per chart review
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06472804
Related Trials
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
NCT04181060604 locations
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
NCT06096844316 locations
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401152 locations
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
NCT070120314 locations
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
NCT066604071 location